Collaborative assessment and management of suicidality at Menninger (CAMS-M): an inpatient adaptation and implementation.
ABSTRACT In this article, the authors describe CAMS-M, a novel approach to working therapeutically with suicidal psychiatric inpatients, with the goal of reducing the likelihood of future suicidal crises. CAMS-M, developed at The Menninger Clinic, is an adaptation of the Collaborative Assessment and Management of Suicidality (CAMS), a novel framework with promising early research findings in outpatient settings (Jobes, 2006). Here, we provide a detailed description of CAMS-M, describe how it differs from CAMS in its original form, and discuss issues around implementation in a hospital setting. We conclude that CAMS-M holds considerable promise in risk management and therapeutic intervention with suicidal patients in the inpatient environment.
Full-textDOI: · Available from: Thomas E Ellis, Jul 05, 2015
- SourceAvailable from: Eoin Galavan[Show abstract] [Hide abstract]
ABSTRACT: ASSESSMENT AND TREATMENT OF SUICIDALITY: WHAT PSYCHOLOGISTS NEED TO KNOW A review of information important for psychologists working with suicidal patients
- [Show abstract] [Hide abstract]
ABSTRACT: Patients hospitalized for psychiatric reasons exhibit significantly elevated risk of suicide, yet the research literature contains very few outcome studies of interventions designed for suicidal inpatients. This pilot study examined the inpatient feasibility and effectiveness of The Collaborative Assessment and Management of Suicidality (CAMS), a structured evidence-based method for risk assessment and treatment planning (Jobes, 2006). The study used an open-trial, case-focused design to assess an inpatient adaptation of CAMS, spread over a period averaging 51 days. The intervention was provided via individual therapy to a convenience sample of 20 patients (16 females and four males, average age 36.9) who were hospitalized with recent histories of suicidal ideation and behavior. Results showed statistically and clinically significant reductions in depression, hopelessness, suicide cognitions, and suicidal ideation, as well as improvement on factors considered "drivers" of suicidality. Treatment effect sizes were in the large range (Cohen's d > .80) across several outcome measures, including suicidal ideation. Although these findings must be considered preliminary due to the lack of a randomized control group, they merit attention from clinicians working with patients at risk for suicide. This study also supports the feasibility of implementing a structured, suicide-specific intervention for at-risk patients in inpatient settings.Psychotherapy Theory Research Practice Training 03/2012; 49(1):72-80. DOI:10.1037/a0026746 · 3.01 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: The Collaborative Assessment and Management of Suicidality (CAMS) is an evidence-based clinical intervention that has significantly evolved over 25 years of clinical research. CAMS is best understood as a therapeutic framework that emphasizes a unique collaborative assessment and treatment planning process between the suicidal patient and clinician. This process is designed to enhance the therapeutic alliance and increase treatment motivation in the suicidal patient. Central to the CAMS approach is the use of the Suicide Status Form (SSF), which is a multipurpose clinical assessment, treatment planning, tracking, and outcome tool. The original development of CAMS was largely rooted in SSF-based quantitative and qualitative assessment of suicidal risk. As this line of research progressed, CAMS emerged as a problem-focused clinical intervention that is designed to target and treat suicidal "drivers" and ultimately eliminate suicidal coping. To date, CAMS (and the clinical use of the SSF) has been supported by six published correlational studies and one randomized clinical trial (RCT). Currently, two well-powered RCTs are under way, and various new CAMS-related projects are also being pursued. The clinical and empirical evolution of CAMS-how it was developed and what are the next steps for this clinical approach-are described here.Suicide and Life-Threatening Behavior 09/2012; 42(6). DOI:10.1111/j.1943-278X.2012.00119.x · 1.40 Impact Factor